TY - JOUR
T1 - Anaphylaxis to Excipients in Current Clinical Practice
T2 - Evaluation and Management
AU - Bruusgaard-Mouritsen, Maria A
AU - Nasser, Shuaib
AU - Garvey, Lene H
AU - Krantz, Matthew S
AU - Stone, Cosby A
N1 - Copyright © 2021 Elsevier Inc. All rights reserved.
PY - 2022
Y1 - 2022
N2 - Excipients are the inactive ingredients in a drug or product that help to stabilize, preserve, or enhance the pharmacokinetics and bioavailability of the active ingredients. Excipient allergy is rare and hence often missed or misdiagnosed due to lack of awareness of the need to carefully review all drug ingredients. For the patient, excipient allergy can be frightening and potentially disruptive to health care delivery. This narrative review provides a clinically oriented, international, collaborative perspective on excipient allergy testing, management of future health care safety, limitations in our testing modalities, and barriers to optimal care.
AB - Excipients are the inactive ingredients in a drug or product that help to stabilize, preserve, or enhance the pharmacokinetics and bioavailability of the active ingredients. Excipient allergy is rare and hence often missed or misdiagnosed due to lack of awareness of the need to carefully review all drug ingredients. For the patient, excipient allergy can be frightening and potentially disruptive to health care delivery. This narrative review provides a clinically oriented, international, collaborative perspective on excipient allergy testing, management of future health care safety, limitations in our testing modalities, and barriers to optimal care.
KW - Anaphylaxis/diagnosis
KW - Excipients/adverse effects
KW - Humans
KW - Pharmaceutical Preparations
U2 - 10.1016/j.iac.2021.12.008
DO - 10.1016/j.iac.2021.12.008
M3 - Review
C2 - 35469617
VL - 42
SP - 239
EP - 267
JO - Immunology and Allergy Clinics of North America
JF - Immunology and Allergy Clinics of North America
SN - 0889-8561
IS - 2
ER -